
Niloofar Rahmani
Examiner (ID: 12602, Phone: (571)272-4329 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625, 1691, 1621 |
| Total Applications | 2303 |
| Issued Applications | 1739 |
| Pending Applications | 128 |
| Abandoned Applications | 466 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7089758
[patent_doc_number] => 20050009871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Ubiquitin ligase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/858537
[patent_app_country] => US
[patent_app_date] => 2004-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24238
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20050009871.pdf
[firstpage_image] =>[orig_patent_app_number] => 10858537
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/858537 | Ubiquitin ligase inhibitors | May 31, 2004 | Issued |
Array
(
[id] => 7378925
[patent_doc_number] => 20040220246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Novel 5-HT3 receptor antagonists and methods of use'
[patent_app_type] => new
[patent_app_number] => 10/857108
[patent_app_country] => US
[patent_app_date] => 2004-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3534
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20040220246.pdf
[firstpage_image] =>[orig_patent_app_number] => 10857108
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/857108 | 5-HT3 receptor antagonists and methods of use | May 27, 2004 | Issued |
Array
(
[id] => 5107785
[patent_doc_number] => 20070066663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => '3-Aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake'
[patent_app_type] => utility
[patent_app_number] => 10/558588
[patent_app_country] => US
[patent_app_date] => 2004-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23907
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0066/20070066663.pdf
[firstpage_image] =>[orig_patent_app_number] => 10558588
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/558588 | 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake | May 24, 2004 | Issued |
Array
(
[id] => 620152
[patent_doc_number] => 07141567
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-11-28
[patent_title] => 'Polysubstituted imidazopyridines as gastric secretion inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/851092
[patent_app_country] => US
[patent_app_date] => 2004-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32024
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/141/07141567.pdf
[firstpage_image] =>[orig_patent_app_number] => 10851092
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/851092 | Polysubstituted imidazopyridines as gastric secretion inhibitors | May 23, 2004 | Issued |
Array
(
[id] => 5829251
[patent_doc_number] => 20060063831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Composition of labdane diterpenes extracted from andrographis paniculata, ufeful for the treatment of autoimmune diseases, and alzheimer disease by activation for ppr-gamma receptors'
[patent_app_type] => utility
[patent_app_number] => 10/516500
[patent_app_country] => US
[patent_app_date] => 2004-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9025
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 55
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20060063831.pdf
[firstpage_image] =>[orig_patent_app_number] => 10516500
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/516500 | Composition of labdane diterpenes extracted from andrographis paniculata, useful for the treatment of autoimmune diseases, and alzheimer disease by activation for PPR-gamma receptors | May 20, 2004 | Issued |
Array
(
[id] => 7218333
[patent_doc_number] => 20050054862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Organo-titanate catalysts for preparing pure macrocyclic oligoesters'
[patent_app_type] => utility
[patent_app_number] => 10/852000
[patent_app_country] => US
[patent_app_date] => 2004-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5923
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054862.pdf
[firstpage_image] =>[orig_patent_app_number] => 10852000
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/852000 | Organo-titanate catalysts for preparing pure macrocyclic oligoesters | May 19, 2004 | Issued |
Array
(
[id] => 5120651
[patent_doc_number] => 20070142366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Jnk inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/554808
[patent_app_country] => US
[patent_app_date] => 2004-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13593
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20070142366.pdf
[firstpage_image] =>[orig_patent_app_number] => 10554808
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/554808 | JNK inhibitors | May 13, 2004 | Issued |
Array
(
[id] => 5120713
[patent_doc_number] => 20070142428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/556356
[patent_app_country] => US
[patent_app_date] => 2004-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3073
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20070142428.pdf
[firstpage_image] =>[orig_patent_app_number] => 10556356
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/556356 | Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof | May 10, 2004 | Issued |
Array
(
[id] => 7693898
[patent_doc_number] => 20070015788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Chemical compounds'
[patent_app_type] => utility
[patent_app_number] => 10/556023
[patent_app_country] => US
[patent_app_date] => 2004-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20694
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20070015788.pdf
[firstpage_image] =>[orig_patent_app_number] => 10556023
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/556023 | Chemical compounds | May 5, 2004 | Issued |
Array
(
[id] => 5890092
[patent_doc_number] => 20060276499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Imidazopyridine intermediates'
[patent_app_type] => utility
[patent_app_number] => 10/555057
[patent_app_country] => US
[patent_app_date] => 2004-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4722
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20060276499.pdf
[firstpage_image] =>[orig_patent_app_number] => 10555057
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/555057 | Imidazopyridine intermediates | May 3, 2004 | Issued |
Array
(
[id] => 5057641
[patent_doc_number] => 20070060563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Quinuclidine derivatives binding to mucarinic m3 receptors'
[patent_app_type] => utility
[patent_app_number] => 10/554558
[patent_app_country] => US
[patent_app_date] => 2004-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24345
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20070060563.pdf
[firstpage_image] =>[orig_patent_app_number] => 10554558
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/554558 | Quinuclidine derivatives binding to mucarinic m3 receptors | Apr 29, 2004 | Abandoned |
Array
(
[id] => 5786782
[patent_doc_number] => 20060205768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Tropane derivatives and their use as ace inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/554704
[patent_app_country] => US
[patent_app_date] => 2004-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6380
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20060205768.pdf
[firstpage_image] =>[orig_patent_app_number] => 10554704
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/554704 | Tropane derivatives and their use as ace inhibitors | Apr 25, 2004 | Abandoned |
Array
(
[id] => 6926779
[patent_doc_number] => 20050240036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Semi-synthesis of taxane intermediates from a mixture of taxanes'
[patent_app_type] => utility
[patent_app_number] => 10/831648
[patent_app_country] => US
[patent_app_date] => 2004-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7306
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20050240036.pdf
[firstpage_image] =>[orig_patent_app_number] => 10831648
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/831648 | Semi-synthesis of taxane intermediates from a mixture of taxanes | Apr 22, 2004 | Abandoned |
Array
(
[id] => 7435657
[patent_doc_number] => 20040266814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Imidazopyridine compounds having 5-HT4 receptor agonistic activity and 5-HT3 receptor antagonistic activity'
[patent_app_type] => new
[patent_app_number] => 10/827701
[patent_app_country] => US
[patent_app_date] => 2004-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10843
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20040266814.pdf
[firstpage_image] =>[orig_patent_app_number] => 10827701
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/827701 | Imidazopyridine compounds having 5-HT4 receptor agonistic activity and 5-HT3 receptor antagonistic activity | Apr 19, 2004 | Abandoned |
Array
(
[id] => 7466785
[patent_doc_number] => 20040198764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Prodrugs of imidazopyridine derivatives'
[patent_app_type] => new
[patent_app_number] => 10/826337
[patent_app_country] => US
[patent_app_date] => 2004-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16298
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198764.pdf
[firstpage_image] =>[orig_patent_app_number] => 10826337
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/826337 | Prodrugs of imidazopyridine derivatives | Apr 18, 2004 | Issued |
Array
(
[id] => 7190832
[patent_doc_number] => 20040204438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Sulfonamide substituted imidazoquinolines'
[patent_app_type] => new
[patent_app_number] => 10/826836
[patent_app_country] => US
[patent_app_date] => 2004-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14319
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20040204438.pdf
[firstpage_image] =>[orig_patent_app_number] => 10826836
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/826836 | Sulfonamide substituted imidazoquinolines | Apr 15, 2004 | Issued |
Array
(
[id] => 460524
[patent_doc_number] => 07241887
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-10
[patent_title] => '3-azabicyclo[3.2.1]octane derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/824037
[patent_app_country] => US
[patent_app_date] => 2004-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31055
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/241/07241887.pdf
[firstpage_image] =>[orig_patent_app_number] => 10824037
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/824037 | 3-azabicyclo[3.2.1]octane derivatives | Apr 13, 2004 | Issued |
Array
(
[id] => 876910
[patent_doc_number] => 07358364
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-15
[patent_title] => 'Substituted carboxylic acids'
[patent_app_type] => utility
[patent_app_number] => 10/823842
[patent_app_country] => US
[patent_app_date] => 2004-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22481
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/358/07358364.pdf
[firstpage_image] =>[orig_patent_app_number] => 10823842
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/823842 | Substituted carboxylic acids | Apr 13, 2004 | Issued |
Array
(
[id] => 5142492
[patent_doc_number] => 20070004708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Condensed n-heterocyclic compounds and their use as crf receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/552493
[patent_app_country] => US
[patent_app_date] => 2004-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42582
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20070004708.pdf
[firstpage_image] =>[orig_patent_app_number] => 10552493
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/552493 | Condensed N-heterocyclic compounds and their use as CRF receptor antagonists | Apr 6, 2004 | Issued |
Array
(
[id] => 5070355
[patent_doc_number] => 20070191457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Compounds having activity at 5ht2c receptor and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/551904
[patent_app_country] => US
[patent_app_date] => 2004-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15563
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20070191457.pdf
[firstpage_image] =>[orig_patent_app_number] => 10551904
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/551904 | Compounds having activity at 5ht2c receptor and uses thereof | Apr 4, 2004 | Abandoned |